Title : Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Pub. Date : 2003 Nov 1

PMID : 14614022






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. GPI 15427 poly (ADP-ribose) polymerase family, member 1 Mus musculus
2 In this study, we tested whether systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase (PARP-1) inhibitor capable of crossing the blood-brain barrier, could enhance the efficacy of TMZ against metastatic melanoma, glioblastoma multiforme, and lymphoma growing in the brain. GPI 15427 poly (ADP-ribose) polymerase family, member 1 Mus musculus
3 CONCLUSIONS: These data indicate that systemic administration of the poly(ADP-ribose) polymerase-1 inhibitor GPI 15427 significantly enhances TMZ antitumor efficacy against solid or hematological neoplasias even when located at the central nervous system site. GPI 15427 poly (ADP-ribose) polymerase family, member 1 Mus musculus